Breaking: Injective Protocol ($INJ) Set For a Comeback The first and only blockchain built for finance that is open, interoperable layer-one blockchain powering next-generation finance applications, including DeFi, RWAs, AI, decentralized exchanges, prediction markets, lending protocols, and more, is set for a comeback with a speculated 140% surge in sight.
Weeks after Breaking down from a rising wedge which is a bearish pattern, CRYPTOCAP:INJ has shown signs of a reversal. With the Relative Strength Index (RSI) already oversold at 28 CRYPTOCAP:INJ is gearing up for a massive comeback with the All-time high of $52.75 a move to the $19 pivot point could spark the resurgence to the recent ATH attained.
Similarly, with growing momentum and the asset trading below key moving averages (MA) CRYPTOCAP:INJ is currently up by 3.41%. The Injective Protocol is becoming an asset worth watching.
Injective Price Live Data
The live Injective price today is $8.77 USD with a 24-hour trading volume of $166,682,991 USD. Injective is down 7.91% in the last 24 hours, with a live market cap of $867,892,886 USD. It has a circulating supply of 98,970,935 INJ coins and the max. supply is not available.
Injectivetrading
Injective- Drop to 20?BINANCE:INJUSDT is another token that has received a lot of hype this year, but, similar to LCX's situation, all this hype hasn't led to a price increase.
If we look at the chart, we can see that after breaking above the important $10 resistance level, the price sharply rose by 400%.
However, after initially surpassing $40, INJ entered a consolidation phase.
Upon examining the weekly chart, it becomes evident that rallies above $40 were met with selling pressure.
Additionally, yesterday, following a new attempt to exceed $40, the price experienced a significant drop. In my view, these are all signs of a potential reversal.
Technically, as previously mentioned, the $40 zone acts as a strong resistance while $30 serves as a clearly defined support level.
A breach below this support could drive the price down to the next support level at $25. However, given the prolonged distribution around the $40 peak, I wouldn't be surprised to see Injective fall to $20 in the long run.
INJUSD Has bottomed and is targeting 33.000Injective is on very stable technicals on the 1D timeframe (RSI = 61.927, MACD = 0.959, ADX = 21.734) as it resumed the rise, keeping clear of the 1D MA50, which remains the Support since since September 29th.
The 1D RSI shows that the market is replicating the early 2023 price action on a fractal which after reclaiming the 1D MA50, it rallied to the 1.5 Fibonacci extension. We therefore turn bullish again, aiming at the 1.5 Fib (TP = 33.000).
## If you like our free content follow our profile to get more daily ideas. ##
## Comments and likes are greatly appreciated. ##